Lawrence Karsh, MD, FACS
No bio available.
Financial relationships
-
Attribution:SelfType of financial relationship:Scientific Study or Trial (Oncology)Ineligible company:AstellasMitigation strategy:Peer reviewDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Scientific Study or Trial (Oncology)Ineligible company:BayerMitigation strategy:Peer reviewDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Scientific Study or Trial (Oncology)Ineligible company:Bristol Myers SquibbMitigation strategy:Peer reviewDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Scientific Study or Trial (Oncology)Ineligible company:JanssenMitigation strategy:Peer reviewDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Scientific Study or Trial (Oncology)Ineligible company:DendreonMitigation strategy:Peer reviewDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:Astra-ZenecaMitigation strategy:Peer reviewDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Scientific Study or Trial (Oncology)Ineligible company:QEDMitigation strategy:Peer reviewDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Scientific Study or Trial (Oncology)Ineligible company:Genomic HealthMitigation strategy:Peer reviewDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:ABBVIEMitigation strategy:Peer reviewDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:UroGPOMitigation strategy:Peer reviewDate reviewed:09/20/2022